D-CSS_Att1_Purchase_Description.pdf
PDF 154 KB Posted
- Solicitation number
- 75N95024Q00573
About this file
This document is a Purchase Description and a Federal Contract Opportunity solicitation for the upgrade of an existing Opera Phenix Plus high content screening system.
The key details are:
The National Center for Advancing Translational Sciences (NCATS) requires an upgrade to an existing Opera Phenix Plus system to provide additional capabilities in environmental control, liquid handling, live imaging, robotic plate handling, image resolution, assay sensitivity, throughput speed, and confocal capability. The upgrade consists of specific brand-name components including a Robot LiveCell system, Environmental Control Upgrade, Liquid Handling System, and 40X Water Objective.
The Federal Contract Opportunity, Solicitation Number 75N95024Q00573, is for a firm fixed-price purchase order for these commercial products, with an anticipated award date of September 12, 2024. The Government will evaluate quotes based on technical capability, price, and past performance. Quotes are due by 4:00 PM EDT on September 9, 2024 and must be submitted by email to the Contracting Officer. The delivery date is within 21 days after receipt of order, with delivery to the National Center for Advancing Translational Sciences in Rockville, MD.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| D-CSS_Att3_Invoicing Instructions With IPP 3-23.pdf | ||
| D-CSS_Att2_FAR_52.212-5_(May_2024).pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
PURCHASE DESCRIPTION
Statement of Need and Purpose:
Upgrade existing Opera Phenix Plus, with the following brand-name or equal components:
(1) One (1) Opera Phenix® Plus Robot LiveCell with LH
(2) One (1) Opera Phenix Plus Environmental Control Upgrade
(3) One (1) Opera Phenix Plus liquid handling System
(4) One (1) Opera Phenix plus water Objective 40X
1. Background Information and Objective:
NCATS requires an upgrade to an existing Opera Phenix Plus in order to provide additional capabilities for:
• Environmental control
• Liquid handling
• Live imaging
• Robotic plate handling
• Image resolution
• Assay sensitivity
• Throughput speed
• Confocal capability
2. Generic Name of Product: High content scanning system (HCSS) upgrade with multiple components.
4. Purchase Description:
Revvity Opera Phenix® Plus Robot LiveCell with LH Revvity Opera Phenix Plus Environmental Control Upgrade Revvity Opera Phenix Plus liquid handling system Revvity Opera Phenix plus water Objective 40X
5. Salient characteristics
The Opera Phenix high content scanning system (HCSS) is a commercially available item that is customized with options to fit the specific laboratory needs. Revvity Health Sciences Opera Phenix High Content Screening Systems that meets the needs of this requirement includes the following Part Numbers: HH14000702, HH18000201, HH20200014, HH20110069 and HH14000422.
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
The salient physical, functional, or performance characteristics that “equal” products must meet are as follows:
1. The customized upgrade must provide the phF Robot LiveCell system for the automation of the multiplate image
2. The customized upgrade must include an environmental chamber to control temperature and carbon dioxide concentration. The environmental chamber must permit use of all optical techniques including transmitted light brightfield and Digital Phase Contrast.
3. The customized upgrade must include liquid handling system to maintain live cell health.
4. The upgrade includes 40X water Objective.
6. Quantity:
One (1) Opera Phenix® Plus Robot LiveCell with LH One (1) Opera Phenix Plus Environmental Control Upgrade One (1) Opera Phenix Plus liquid handling System One (1) Opera Phenix plus water Objective 40X
7. Delivery Date and Period of performance
2-3 weeks ARO
8. Delivery Location Address: National Center for the Advancement of Translational Sciences, 9800 Medical Center Dr, Rockville, MD 20850 Attention: Wei Zheng
File details come from the government source that posted it. Updated .